Pancreatectomy with concomitant portal vein resection in the current neoadjuvant era

作     者：Benedetto Ielpo Fernando Burdio Ana Martinez Patricia Sanchez-Velazquez 

作者机构：Hepato-Biliary and Pancreatic Surgery UnitHospital del MarUniversitat Pompeu FabraBarcelonaSpain 

出 版 物：《Hepatobiliary Surgery and Nutrition》 (肝胆外科与营养（英文）)

年 卷 期：2022年第11卷第2期

页      面：295-298页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：resection death 

摘      要：I’ve read with great interest the paper of Machairas et al.(1)which is of great interest for the oncological and surgical *** adenocarcinoma(PDAC)is still considered a malignancy with an extremely poor prognosis,being currently the 4th cause of death for cancer and,according to the Global Cancer Statistics in the next decade,it may ascend up to the third cause of death(2).During the last decades,there have been great efforts to improve survival of potentially resectable pancreatic cancer through several ***,the selection of patients:newer preoperative studies have been able to select those patients that might really benefit from ***,the surgical procedure itself improved its outcome:proper mesopancreatic dissection and lymphadenectomy,superior mesenteric artery approach and vascular resection have been able to enhance the R0 resection rate with acceptable morbidity(3).Finally,newer chemotherapies regimens have been introduced,as well,with relevant survival improvement(4).